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Robotic surgery is minimally invasive interventions 
performed with the help of a surgical robot. Instead 
of the surgeon directly holding surgical instruments, 
robotic arms hold the specifically designed keyhole 
instruments; the surgeon then takes full control of the 
robot and moves them through a console using joysticks. 
The robotic instruments are agile and offer 7° of freedom 
so that the surgeon can easily access complex and oddly 
located pathologies precisely. It is worth mentioning that 
the human arm although more dexterous also has seven 
degrees of freedom; therefore, the robotic surgery offers 
the freedom of movements of a human arm in a minimally 
invasive environment. The three-dimensional (3D) view 
of the robotic console improves surgeon’s perception of 
operative field and offers superior assessment of index 
pathology with the advantage that the robotic arm can 
operate in the micrometre range much more precisely 
than the actual surgeon can.
Robotic surgery has been around for nearly 30 years 
now. The first documented procedure performed with 
robotic assistance was in 1985 when brain biopsies were 
taken using PUMA surgical robot. Since then, the robotic 
surgery has grown leaps and bounds. The first Robotic 
cholecystectomy was performed in 1987 and transurethral 
resection of the prostate in 1988. The US government 
was more interested in the use of surgical robot in NASA 
and the U.S. Army-Mobile Advanced Surgical Hospital 
missions. The idea was that a specialist surgeon could 
remotely operate on a patient in space or battlefield. 
Working on this theme, a trans-Atlantic cholecystectomy 
was performed by a surgeon in the US on a patient in 
France. The procedure went well, but the hands across the 
oceans[1] approach could not get widespread acceptance.
In 2000, the da Vinci® became the first surgical robotic 
system approved by the FDA for general laparoscopic 
surgery. This initiated beginning of the ever more exciting 
robotic surgery era. At present, almost all surgical 
specialties have and are performing robotic surgery to 
some extent. Urology has taken a lead on this, and due 
to superior nerve sparing and preservation of function, 
robotic radical prostatectomy has become the standard 
of care in certain places.[2]
Hence, what are the advantages and disadvantages of 
robotic surgery?
There is no doubt that robotic approach provides a better 
solution for the technical limitations of the conventional 
minimally invasive techniques. Robotic arms allow 
increased range of movements and due to their wristed 
character, robotic instruments offer extended freedom 
as compared to laparoscopic instruments. The robot can 
filter physiologic tremors, increases ergonomics, and 
offers unmatched 3D view of the surgical field. It has 
been shown that robotic approach helps provide higher 
level of precision, a superior 3D visualisation with 
better assessment of tissue depth, and improve dexterity 
compared to the conventional laparoscopic technique.[3]
The main disadvantage of robotic surgery is its cost. 
Surgical robot is expansive to buy and costs between 1.5 
and 2 million pounds. Moreover, the robotic instruments 
are expansive to use. For example, robotic monopolar 
hook costs £1750 and can be used 10 times only. 
Moreover, there is no haptic feedback while operating 
through the console, the surgeon has to work using the 
visual feedback only and this requires time and training 
to develop. It is not difficult to lose sight of additional 
robotic arms in the surgical field which, in turn, can cause 
unseen damage outside the view of the surgeon. Therefore, 
a structured and modular training is required before one 
can start using the surgical robot on patients.
Robotic training systems are developing and Intuitive® 
who owns and market da Vinci® robot have come up with 
a training pathway in the UK which starts with orientation 
module followed by 30 h of training on the simulator. 
This then leads on to an online module and assessment 
that must be passed. A one-to-one service module is then 
undertaken with Intuitive® representative following which 
the trainee surgeon is taken to a wet laboratory for training 
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on live animal. Surgeon has to pass the assessment at the 
animal laboratory and will then be taken to a cadaver 
laboratory for dissection and experience on human body. 
Trainee surgeon is also taken for case observations at 
units that perform robotic surgery regularly and also to 
give him the opportunity to choose a mentor and proctor. 
After passing all the assessment and approval from 
hospital clinical governance, ethical, safety, and finance 
committees, robotic surgery can be undertaken on eligible 
patients. Initially, all cases are performed while a proctor 
is present within the theatres. The role of the proctor is to 
advise on the set up of surgical robot and offer guidance 
and help during the procedure as needed. The proctor 
has to write an assessment report on the surgeon’s level 
of skills and safe use of the robot and can sign him off to 
undertake the procedure independently.
The role of robotic surgery in hepatobiliary and pancreatic 
surgery (HPB) as a superspecialty is developing. At 
present, very few surgeons in the world perform complex 
operations on liver, pancreas, and bile duct with robotic 
assistance. In the UK, robotic HPB surgeons can be 
counted on the fingers of one hand.
University Hospital Coventry and Warwickshire NHS 
Trust started their robotic HPB surgery program at in April 
2018. We started with some cholecystectomies to learn 
setting up the robot and understand its philosophy and 
working. Since then, we have performed over 50 cases 
including Whipple’s procedure, distal pancreatectomy 
with and without spleen preservation, splenectomy, 
excision of extrahepatic biliary tree with Roux-en-Y 
reconstruction, right hepatectomy, left hepatectomy, left 
lateral sectionectomy, and atypical liver resections. We 
have had no mortalities and our morbidity rates are well 
below that of both open and laparoscopic approach. We 
plan to publish our detailed results in near future.
The advantages of robotic pancreatic surgery are various. 
Precise dissection, ease of suturing, control of pedicles, 
and access to difficult pathology are only to name a few.[4] 
In our opinion, one of the most important advantage, for 
example, of robotic Whipple’s as compared to laparoscopic 
Whipple’s is that the surgeon is sitting on a chair while 
working on the console, the camera is held by the robot 
and this long robotic procedure (8–10 h at our hospital) 
can be completed in a pleasant environment without 
surgeon or assistant fatigue. We know many of our HPB 
colleagues dread laparoscopic Whipple’s as it is physically 
challenging for both the surgeon and assistant. Robotic 
assistance will ensure longevity of a surgeon’s professional 
career and he can go on to perform long and complex 
procedures while he gracefully gets older and hopefully 
wiser while working for the best interest of his patients.
Advantage of robotics in liver surgery can be explained 
by the fact that it provides the operating surgeon ability 
to dissect and suture precisely in small difficult to reach 
locations such as the posterosuperior segments of the liver 
(Segment VII and VIII). Robotic technique facilitates 
curved transection lines, thus allows more complex 
resections to be done minimally invasively.[5] It must be 
acknowledged that at present we do not have an ideal 
tool for parenchymal transection in either laparoscopic 
or robotic surgery. Cavitron Ultrasonic Surgical Aspirator 
(CUSA) is the gold standard for liver parenchymal 
transection as it offers superior dissection of Glissonian 
pedicles with precise control and lower blood loss. The 
laparoscopic CUSA is available but due to distant fulcrum 
at the laparoscopic port sites, is not precise, and is difficult 
to use. There is no equivalent instrument in robotic surgery 
at present. Parenchymal transection during robotic surgery 
is undertaken with either a non-wristed Harmonic® or 
wristed da Vinci® Vessel sealer which is bulky and does not 
offer CUSA equivalent parenchymal transection. Usually, 
the surgeon has to make do with monopolar scissors and 
bipolar fenestrated graspers.
In summary, robotic surgery is an exciting development 
and makes minimally invasive surgery possible in 
otherwise challenging cases. The cost of robotic surgery 
has limited its widespread use in the world. With the 
development of new robotic systems (e.g., Google-Ethicon 
surgical robot), the economics of robotic surgery is likely 
to improve. Robotic HPB is challenging but extremely 
rewarding and with emerging evidence will secure its 
place in most operating theatres.
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